<p>OR: odds ratio; P: p value of heterogeneity; HB: hospital-based; PB: population-based; *significant association.</p
<p>HB, Hospital based; PB, Population based; FB, Family based; NHL, non-Hodgkin lymphoma; SCCHN, Squ...
Background. The purpose of this study was to investigate the association between the peptidyl-propyl...
polymorphism rs401681 was of special interest for cancers risk but with inconclusive results.<0.001...
<p>A: dominant model (GC+CC vs. GG) calculated with genotype distribution data; B dominant model (GC...
Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer deve...
Published evidence suggests that the rs2233678 (−842 G>C) polymorphism in the PIN1 (peptidyl-prolyl ...
<p>A: heterozygote comparison (TC vs. TT) estimated with genotype distribution data; B heterozygote ...
Background: Peptidylprolyl cis/trans isomerase NIMA-interacting 1 (PIN1) is involved in the process ...
Background: Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1 (PIN1) plays an important role in...
Peptidylprolyl cis/trans isomerase NIMA-interacting 1 (PIN1) is involved in the process of tumorigen...
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer deve...
BACKGROUND: Published evidence suggests that the rs2233678 (-842 G>C) polymorphism in the PIN1 (pept...
<p>N: number of studies; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; <b>*OR</b> with s...
<p>Odds ratios (OR), 95% confidence intervals (95% CI) and P-values obtained using the unconditional...
<p>Notes: CI, confidence interval; CRC, colorectal cancer; OR, odds ratio; PC, prostate cancer.</p><...
<p>HB, Hospital based; PB, Population based; FB, Family based; NHL, non-Hodgkin lymphoma; SCCHN, Squ...
Background. The purpose of this study was to investigate the association between the peptidyl-propyl...
polymorphism rs401681 was of special interest for cancers risk but with inconclusive results.<0.001...
<p>A: dominant model (GC+CC vs. GG) calculated with genotype distribution data; B dominant model (GC...
Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer deve...
Published evidence suggests that the rs2233678 (−842 G>C) polymorphism in the PIN1 (peptidyl-prolyl ...
<p>A: heterozygote comparison (TC vs. TT) estimated with genotype distribution data; B heterozygote ...
Background: Peptidylprolyl cis/trans isomerase NIMA-interacting 1 (PIN1) is involved in the process ...
Background: Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1 (PIN1) plays an important role in...
Peptidylprolyl cis/trans isomerase NIMA-interacting 1 (PIN1) is involved in the process of tumorigen...
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer deve...
BACKGROUND: Published evidence suggests that the rs2233678 (-842 G>C) polymorphism in the PIN1 (pept...
<p>N: number of studies; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; <b>*OR</b> with s...
<p>Odds ratios (OR), 95% confidence intervals (95% CI) and P-values obtained using the unconditional...
<p>Notes: CI, confidence interval; CRC, colorectal cancer; OR, odds ratio; PC, prostate cancer.</p><...
<p>HB, Hospital based; PB, Population based; FB, Family based; NHL, non-Hodgkin lymphoma; SCCHN, Squ...
Background. The purpose of this study was to investigate the association between the peptidyl-propyl...
polymorphism rs401681 was of special interest for cancers risk but with inconclusive results.<0.001...
DOI
Add to ORKG